These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 9445193

  • 1. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.
    Cancer; 1998 Jan 15; 82(2):349-54. PubMed ID: 9445193
    [Abstract] [Full Text] [Related]

  • 2. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul 15; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T.
    APMIS; 2009 Jan 15; 117(1):45-52. PubMed ID: 19161536
    [Abstract] [Full Text] [Related]

  • 4. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar 15; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 5. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T, Kinjo M, Nutahara K, Higashihara E.
    J Urol; 2004 Apr 15; 171(4):1461-6. PubMed ID: 15017198
    [Abstract] [Full Text] [Related]

  • 6. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ, Weitz J, Kienle P, Lacroix J, Wiesel MJ, Soder M, Benner A, Staehler G, Doeberitz MV.
    J Urol; 2000 Aug 15; 164(2):532-6. PubMed ID: 10893639
    [Abstract] [Full Text] [Related]

  • 7. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar 15; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung.
    Chausovsky G, Luchansky M, Figer A, Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S, Klein A.
    Cancer; 1999 Dec 01; 86(11):2398-405. PubMed ID: 10590383
    [Abstract] [Full Text] [Related]

  • 12. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ, Mengual L, Marín M, Algaba F, Ars E, Fernández PL, Oliva R, Villavicencio H, Alcaraz A.
    Anticancer Res; 2006 Dec 01; 26(1A):411-9. PubMed ID: 16475726
    [Abstract] [Full Text] [Related]

  • 13. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
    Gazzaniga P, Gandini O, Giuliani L, Magnanti M, Gradilone A, Silvestri I, Gianni W, Gallucci M, Frati L, Aglianò AM.
    Clin Cancer Res; 2001 Mar 01; 7(3):577-83. PubMed ID: 11297251
    [Abstract] [Full Text] [Related]

  • 14. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 01; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B, Barak V, Shapiro A, Golijanin D, Peretz T, Pode D.
    Cancer; 2002 Jun 01; 94(11):2914-22. PubMed ID: 12115379
    [Abstract] [Full Text] [Related]

  • 16. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
    Fishman A, Klein A, Zemer R, Zimlichman S, Bernheim J, Cohen I, Altaras MM.
    Gynecol Oncol; 2000 Jun 01; 77(3):399-404. PubMed ID: 10831349
    [Abstract] [Full Text] [Related]

  • 17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Jun 01; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug 01; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.